These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 33130275)
1. COVID-19 and antimalarials. Have we been doing it wrong all along? Cismaru CA; Cismaru GL; Seyed Nabavi F; Seyed Nabavi M; Berindan-Neagoe I Eur J Pharmacol; 2021 Jan; 891():173694. PubMed ID: 33130275 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Gautret P; Lagier JC; Honoré S; Hoang VT; Raoult D Int J Antimicrob Agents; 2021 Jan; 57(1):106242. PubMed ID: 33408033 [No Abstract] [Full Text] [Related]
3. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Gautret P; Lagier JC; Honoré S; Hoang VT; Colson P; Raoult D Int J Antimicrob Agents; 2021 Jan; 57(1):106243. PubMed ID: 33408014 [No Abstract] [Full Text] [Related]
4. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis. Million M; Roussel Y; Gautret P; Raoult D Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019 [No Abstract] [Full Text] [Related]
5. Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Goldman JD; Diaz G; Urba WJ Int J Antimicrob Agents; 2021 Jan; 57(1):106174. PubMed ID: 33408020 [No Abstract] [Full Text] [Related]
6. Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. Nguyen TV Int J Antimicrob Agents; 2021 Jan; 57(1):106169. PubMed ID: 33408026 [No Abstract] [Full Text] [Related]
7. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Gautret P; Honoré S; Lagier JC; Raoult D Int J Antimicrob Agents; 2021 Jan; 57(1):106236. PubMed ID: 33408025 [No Abstract] [Full Text] [Related]
8. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. Fantini J; Chahinian H; Yahi N Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32862840 [TBL] [Abstract][Full Text] [Related]
9. An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia. Purwati ; Miatmoko A; Nasronudin ; Hendrianto E; Karsari D; Dinaryanti A; Ertanti N; Ihsan IS; Purnama DS; Asmarawati TP; Marfiani E; Yulistiani ; Rosyid AN; Wulaningrum PA; Setiawan HW; Siswanto I; Tri Puspaningsih NN PLoS One; 2021; 16(6):e0252302. PubMed ID: 34143818 [TBL] [Abstract][Full Text] [Related]
10. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Colson P; La Scola B; Lagier JC; Gautret P; Raoult D Int J Antimicrob Agents; 2021 Jan; 57(1):106238. PubMed ID: 33408030 [No Abstract] [Full Text] [Related]
11. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Cochin M; Touret F; Driouich JS; Moureau G; Petit PR; Laprie C; Solas C; de Lamballerie X; Nougairède A Antiviral Res; 2022 Jan; 197():105212. PubMed ID: 34838583 [TBL] [Abstract][Full Text] [Related]
12. Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies. Zhai MZ; Lye CT; Kesselheim AS JAMA Intern Med; 2020 Sep; 180(9):1145-1146. PubMed ID: 32427277 [No Abstract] [Full Text] [Related]
13. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Hache G; Rolain JM; Gautret P; Deharo JC; Brouqui P; Raoult D; Honoré S Microb Drug Resist; 2021 Mar; 27(3):281-290. PubMed ID: 33729874 [TBL] [Abstract][Full Text] [Related]
14. Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial. Dos Santos MR Int J Antimicrob Agents; 2021 Jan; 57(1):106176. PubMed ID: 33408022 [No Abstract] [Full Text] [Related]
15. Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". Saad MO Int J Antimicrob Agents; 2021 Jan; 57(1):106171. PubMed ID: 33408024 [No Abstract] [Full Text] [Related]
16. Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial". Wambier CG Int J Antimicrob Agents; 2021 Jan; 57(1):106175. PubMed ID: 33408021 [No Abstract] [Full Text] [Related]
17. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304 [TBL] [Abstract][Full Text] [Related]
18. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Gautret P; Hoang VT; Lagier JC; Raoult D Int J Antimicrob Agents; 2021 Jan; 57(1):106239. PubMed ID: 33408029 [No Abstract] [Full Text] [Related]
19. Can we use hydroxychloroquine to treat COVID-19 now? Chen J; Liu D; Yin L; Zhang L; Lu H Int J Antimicrob Agents; 2021 Jan; 57(1):106173. PubMed ID: 33408016 [No Abstract] [Full Text] [Related]
20. Doxycycline as an Alternative to Azithromycin in Elderly Patients. Malek AE; Granwehr BP Int J Antimicrob Agents; 2021 Jan; 57(1):106168. PubMed ID: 33408018 [No Abstract] [Full Text] [Related] [Next] [New Search]